Latest Asx Company Filings News

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.

Smart Parking Limited reports robust H1 FY25 growth driven by a strategic US acquisition and expanding global footprint, underpinned by proprietary AI technology.

Elixinol Wellness Limited is poised to lift its trading suspension on May 22, 2025, following a significant announcement regarding its financing and capital structure.

New World Resources Limited has entered a binding agreement for acquisition by Central Asia Metals Plc at a significant premium, valuing the company at approximately A$185 million. The transaction, unanimously recommended by New World’s board, is set to complete by September 2025, subject to shareholder and court approvals.

London City reports a record investment portfolio value of $27.3 million, buoyed by strong gains in Fiducian Group shares, while legal proceedings against Excelsior Capital and its directors continue to unfold.

Havilah Resources reports robust drilling, metallurgical, and mining study outcomes at its Mutooroo copper-cobalt-gold project, with JX Advanced Metals Corporation negotiating a pre-feasibility study agreement that could lead to equity investment.

Aguia Resources has initiated gold sales from its Santa Barbara Project in Colombia, marking a significant step as the company ramps up production and advances operational capacity.

Polymetals Resources reports steady progress at its Endeavor silver zinc mine with commissioning underway and first cash flow anticipated in June 2025. Mining volumes are ramping up ahead of schedule, setting the stage for a promising production phase.

Bryah Resources has secured an option to acquire the Golden Pike high-grade gold project in New Brunswick, Canada, featuring a historical inferred resource of over 66,000 ounces of gold. The move positions Bryah to capitalize on strong gold prices with plans for extensive exploration and resource upgrade.

Mayne Pharma has firmly rejected Cosette Pharmaceuticals’ assertion of a Material Adverse Change that could derail their acquisition scheme, insisting the deal process continues as planned.

Aurum Resources reports significant shallow, high-grade gold intercepts at its Boundiali Gold Project in Côte d'Ivoire, underpinning ambitious drilling and resource expansion plans for 2025.

Adavale Resources has reported a standout 22.2g/t gold assay from rock chip sampling at its newly defined Parkvale South prospect within the Parkes Project in NSW, highlighting a promising exploration advance ahead of planned drilling.